Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from the date of first infusion of study treatment to the date of study termination, assessed up to 72 months
Awards & highlights
Study Summary
This trial is testing a new combination regimen for patients with advanced solid tumors.
Eligible Conditions
- Advanced Solid Tumors
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from the date of first infusion of study treatment to the date of study termination, assessed up to 72 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from the date of first infusion of study treatment to the date of study termination, assessed up to 72 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Overall response rate
Patients with dose limiting toxicities
Secondary outcome measures
Clinical Benefit Rate
Duration of Response
Incidence of Treatment-Emergent Adverse Events
+7 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: PM14Experimental Treatment1 Intervention
Patients will receive PM14 as an i.v. infusion in a total volume of 100 mL of 0.9% sodium chloride at the first three dose escalation levels. Thereafter, the volume of infusion can be increased to 250 mL.
Find a Location
Who is running the clinical trial?
PharmaMarLead Sponsor
90 Previous Clinical Trials
11,387 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger